How a Chinese hematology analyzer is reshaping high-volume lab diagnostics

Mindray BC-6800Plus 5-Part Differential Hematology Analyzer

For hospital labs processing hundreds of complete blood counts daily, throughput is not a luxury — it’s a bottleneck. The BC-6800Plus directly addresses that constraint, delivering 200 tests per hour with 5-part WBC differential, NRBC detection, and reticulocyte analysis built into a single workflow.

Mindray’s proprietary SF Cube technology drives the core optical system, using fluorescent staining to differentiate cell populations with higher sensitivity than conventional impedance-based methods. That translates into fewer false flags and more reliable platelet and reticulocyte counts — a real operational gain for labs that manage high proportions of abnormal samples.

The machine’s automatic rerun and reflex testing eliminate a major source of technician time waste. When a result triggers a predefined threshold, the analyzer takes action without human intervention. In high-volume settings, that loop closure can shave hours off daily operations.

With the BC-6800Plus, Mindray is competing directly against Sysmex and Beckman Coulter in the mid-to-high-throughput segment. Its aggressive feature set — including automatic neutrophil-to-lymphocyte ratio calculation — reflects a strategy of over-delivering on clinical utility to gain traction in cost-sensitive markets.

China’s diagnostic manufacturing ecosystem now produces analyzers that match incumbent performance at lower acquisition and reagent costs. For procurement teams at tier-2 and tier-3 hospitals, that calculus shifts the adoption curve.

Why it matters:
Labs that standardize on the BC-6800Plus gain a complete hematology pipeline without third-party add-ons. For operators, it means lower per-test cost, less downtime, and better abnormal cell detection — without the premium price tag of legacy vendors.

View Product →